Status:
UNKNOWN
Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes
Lead Sponsor:
Taichung Veterans General Hospital
Collaborating Sponsors:
Tri-Service General Hospital
Conditions:
Diabetes Mellitus
Impaired Glucose Tolerance
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
To understand if acarbose, an alpha-glucosidase inhibitor usually for treating diabetes, will further lower post meal glucose and inflammatory state when taking together with moderate amount of alcoho...
Eligibility Criteria
Inclusion
- Subjects with mild diabetes without prior medications or impaired glucose tolerance
Exclusion
- Pregnancy
- Recent major cardiac, renal and hepatic disease
- Intolerance to alcohol
- Allergy to acarbose treatment
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00417950
Start Date
January 1 2007
Last Update
January 4 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Veterans General Hospital
Taichung, Taiwan